![Nicole Onetto](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicole Onetto
Directeur/Membre du Conseil chez
BOLT BIOTHERAPEUTICS, INC.
Fortune : 113 155 $ au 31/05/2026
Profil
Nicole M.
Onetto is currently an Independent Non-Executive Director at Basilea Pharmaceutica AG since 2017, an Independent Director at Bolt Biotherapeutics, Inc. since 2021, and a Director at CDR-Life AG since 2022.
Former roles include Senior Director-Medical Affairs at Bristol Myers Squibb Co. from 1991 to 1997, Independent Director at ImmunoGen, Inc. from 2011 to 2016, Director at YM BioSciences, Inc. from 2014 to 2015, Independent Director at Sierra Oncology, Inc. from 2015 to 2019, Independent Director at Sunesis Pharmaceuticals, Inc. from 2019 to 2021, Deputy Director & Chief Scientific Officer at Ontario Institute for Cancer Research from 2013 to 2016, Director at NBE-Therapeutics AG from 2017 to 2021, Independent Director at Viracta Therapeutics, Inc. from 2021 to 2023, Senior Vice President-Medical Affairs at Gilead Sciences, Inc. in 2001, Chief Medical Officer & Executive Vice President at OSI Pharmaceuticals, Inc. from 2002 to 2005, Vice President-Medical Affairs at NeXstar Pharmaceuticals, Inc. from 1997 to 1999, and Chief Medical Officer & Senior Vice President at ZymoGenetics, Inc. from 2005 to 2009.
Education includes graduate studies at the University of Montréal and undergraduate and doctorate degrees from Université de Paris 5 René Descartes.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BASILEA PHARMACEUTICA AG 0,01 % | 31/12/2025 | 1 697 ( 0,01 % ) | 113 155 $ | 31/05/2026 |
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Nicole Onetto
| Sociétés | Poste | Début |
|---|---|---|
| BASILEA PHARMACEUTICA AG | Directeur/Membre du Conseil | 27/04/2017 |
| BOLT BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 14/12/2021 |
CDR-Life Inc.
 CDR-Life Inc. BiotechnologyHealth Technology Operates as a biotherapeutics company | Directeur/Membre du Conseil | 08/12/2022 |
Anciens postes connus de Nicole Onetto
| Sociétés | Poste | Fin |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 08/06/2023 |
| VIRACTA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/02/2021 |
NBE-Therapeutics AG
 NBE-Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops antibody drug conjugates and advancing targeted cancer therapies | Directeur/Membre du Conseil | 01/01/2021 |
| SIERRA ONCOLOGY, INC. | Directeur/Membre du Conseil | 22/11/2019 |
| IMMUNOGEN, INC. | Directeur/Membre du Conseil | 09/12/2016 |
Formation de Nicole Onetto
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
NeXstar Pharmaceuticals, Inc.
 NeXstar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
YM BioSciences, Inc.
 YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Basilea Pharmaceutica AG
 Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of Montréal
 University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ontario Institute for Cancer Research
 Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Provides research on the prevention, early detection, diagnosis, and treatment of cancer | Health Services |
Université de Paris 5 René Descartes
 Université de Paris 5 René Descartes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NBE-Therapeutics AG
NBE-Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops antibody drug conjugates and advancing targeted cancer therapies | Health Technology |
Bolt Biotherapeutics, Inc.
 Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
CDR-Life Inc.
CDR-Life Inc. BiotechnologyHealth Technology Operates as a biotherapeutics company | Health Technology |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
